NMDA Receptors (NMDA-Rs) are ionotropic glutamate receptors, which associate with LDL Receptor-related Protein-1 (LRP1) to trigger cell-signaling in response to protein ligands in neurons. Herein, we demonstrate for the first time that the NMDA-R is expressed by rat Schwann cells (SCs) and functions independently and with LRP1 to regulate SC physiology. The NR1 and NR2b NMDA-R subunits were expressed by cultured SCs and up-regulated in sciatic nerves following crush injury. The ability of LRP1 ligands to activate ERK1/2 and promote SC migration required the NMDA-R. NR1 gene-silencing compromised SC survival. Injection of the LRP1 ligands, tissue-type plasminogen activator (tPA) or MMP9-PEX, into crush-injured sciatic nerves, activated ERK1/2 in SCs in vivo and the response was blocked by systemic treatment with the NMDA-R inhibitor, MK801. tPA was unique amongst the LRP1 ligands examined because tPA activated cell-signaling and promoted SC migration by interacting with the NMDA-R independently of LRP1, albeit with delayed kinetics. These results define the NMDA-R as a SC signaling receptor for protein ligands and a major regulator of SC physiology, which may be particularly important in PNS injury.
Introduction
transfected with NTC siRNA, were uniformly immunopositive for NR1. NR1 genesilencing eliminated the NR1 IF signal in essentially all of the cells.
NMDA-R is necessary for LRP1 signaling in SCs
Binding of ligands to LRP1 regulates diverse cell-signaling pathways in SCs (Mantuano et al., 2008; Mantuano et al., 2010) . In this study, we examined ERK1/2 phosphorylation as an indicator of the multifaceted LRP1 signaling response. Fig. 2A shows that the LRP1 ligands, activated α2M (α2M*) (10 nM) and enzymatically-inactive tPA (EI-tPA) (12 nM), activated ERK1/2 in cultured SCs. To confirm that this signaling response requires LRP1, we pre-treated SCs with receptor-associated protein (RAP), which was expressed as a GST-fusion protein (GST-RAP) (150 nM). RAP is a well-established LRP1 cellsignaling antagonist . We also pre-treated cells with lactoferrin (LF) (150 nM), which in neurons and neuron-like cells, functions similarly to RAP, binding to LRP1 and preventing activation of cell-signaling by other ligands (Mantuano et al., 2013) . RAP and lactoferrin both blocked ERK1/2 activation in SCs in response to α2M* and EI-tPA.
In neurons, LRP1 signaling requires the NMDA-R as an essential co-receptor (Backsai et al., 2000; Qiu et al., 2003; Samson et al., 2008; Martin et al., 2008; Sheng et al., 1008; Mantuano et al., 2013) . Other LRP1 co-receptors in neurons include Trk receptors and p75 NTR (Shi et al., 2009; Yoon et al., 3013; Stiles et al., 2013) . Very little is known about the molecular nature of the LRP1 signaling system in other cell types.
To test whether the NMDA-R is required for LRP1 signaling in SCs, first we pre-treated SCs with MK801 (1 µM), an uncompetitive antagonist of the NMDA-R. Fig. 2B shows that MK801 blocked ERK1/2 phosphorylation in response to α2M* and EI-tPA. In control experiments, we demonstrated that MK801 and the LRP1 antagonists, RAP and lactoferrin, do not independently regulate phospho-ERK1/2 in SCs (Fig. 2C ). MK801 also inhibited ERK1/2 activation in response to a GST-fusion protein that contains the hemopexin domain of MMP9 (GST-PEX, 20 nM), known to bind to LRP1 (Mantuano et al., 2008) (Fig. 2D ).
was significantly increased in cells in which the NR1 gene was silenced (p<0.05) (Fig.   4C ). We therefore conclude that the effects of NMDA-R NR1 gene-silencing are equivalent to those observed when LRP1 is silenced or when its activity antagonized (Campana et al., 2006; Mantuano et al., 2008) .
SC NMDA-R activates cell-signaling in response to tPA independently of LRP1
In neurons, tPA may trigger cell signaling through a direct interaction with the NMDA-R, independently of LRP1 (Nicole et al., 2001; Macrez et al., 2010; Ng et al., 2012; Mantuano et al., 2013) . To determine whether the NMDA-R signals in response to tPA, independently of LRP1 in SCs, we treated SCs with 12 nM EI-tPA in the presence or absence of RAP for up to 60 min. At 15 min, RAP blocked the response to EI-tPA, confirming the results of experiments reported in Fig. 1A . However, by 30 min, ERK1/2 was activated even when binding of EI-tPA to LRP1 was prevented with RAP ( Fig. 5A ).
The activity of RAP, blocking ERK1/2 phosphorylation in response to EI-tPA, also was overcome by increasing the EI-tPA concentration (Fig. 5B) . These results suggest that in SCs, as in PC12 and N2A cells (Mantuano et al., 2013) , EI-tPA signals by binding to the NMDA-R, independently of LRP1; however, LRP1 facilitates a more rapid response or increases the sensitivity of the system.
As a control, we studied the SC response to 10 nM α2M* as a function of time, up to 60 min, in the presence or absence of RAP. We selected α2M* for these control experiments because the binding affinity of α2M* for LRP1 is much higher than the affinity of tPA for LRP1 (Ney et al., 1985; Hussaini et al., 1990; Bu et al., 1992) . Although ERK1/2 was robustly activated by α2M* in the absence of RAP through the entire 60 min time course, when RAP was present, phospho-ERK1/2 was not observed (Fig. 5C ).
Increasing the concentration of α2M* to 60 nM also failed to overcome the activity of RAP (Fig. 5D) . Thus, for α2M*-initiated cell-signaling in SCs, unlike cell-signaling stimulated by EI-tPA, the requirement for LRP1 appears absolute. For both EI-tPA and α2M*, the requirement for NMDA-R is absolute.
To further test whether EI-tPA interacts with the NMDA-R to regulate SC physiology in the absence of LRP1, we examined the ability of EI-tPA to stimulate SC migration in the presence of RAP. As shown in Fig. 6A , SC migration in response to 12 nM EI-tPA was blocked by 150 nM RAP. By contrast, 60 nM EI-tPA overcame the inhibitory effects of RAP, stimulating cell migration 5.4 ± 0.3-fold. As a control, we examined cell migration in response to different concentrations of α2M*. As shown in Fig. 6B , α2M* failed to promote SC migration in the presence of 150 nM RAP when added at a concentration of 10 nM or 60 nM.
As a second approach to study the effects of EI-tPA on SC migration in the absence of LRP1, we silenced LRP1 expression in SCs, as previously described (Mantuano et al., 2008) . Compared with cells transfected with NTC siRNA, LRP1 genesilenced cells demonstrated >95% reduction in LRP1 mRNA (results not shown). Fig.   6C shows that LRP1 gene silencing blocked SC migration in response to 12 nM EI-tPA.
In response to 60 nM EI-tPA, a breakthrough response was observed; migration was stimulated 3.2 ± 0.2-fold (p<0.01). SC migration in response to 12 nM EI-tPA or 60 nM EI-tPA was totally inhibited by MK801 (Fig. 6D) .
Enzymatically active and inactive tPA activate cell-signaling in SCs similarly
When the enzymatic activity of tPA is not blocked, the NR1 subunit of the NMDA-R may be cleaved (Nicole et al., 2001) . Active tPA also may release LRP1 from the surfaces of cells (Polavarapu et al., 2007) . We therefore conducted cell-signaling experiments to determine whether enzymatically active (EA) and inactive tPA yield equivalent results. Fig. 7A shows that EA-tPA activated ERK1/2 in cultured SCs. The response was blocked by RAP when the concentration of EA-tPA was 12 nM; however, the inhibitory activity of RAP was overcome by higher concentrations of EA-tPA (60 nM). Extending the incubation time also overcame the inhibitory activity of RAP (Fig. 7B ). ERK1/2 activation in response to EA-tPA was blocked by MK801 (Fig. 7C) . These results suggest that EA-tPA and EI-tPA activate cell-signaling in SCs equivalently.
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Sciatic nerve crush injury promotes expression of SC NMDA-R In rats, LRP1 expression is robustly increased in SCs in response to PNS injury (Campana et al., 2006) . SCs account for >90% of the mRNA present in the un-injured PNS and in the injured PNS for up to 2-3 days, before inflammatory cells infiltrate the injury site in significant numbers (Asbury and Johnson, 1978) . We therefore performed RT-qPCR to test the effects of sciatic nerve crush injury on NMDA-R subunit expression in vivo. Fig. 8A shows that LRP1 mRNA was significantly increased in the distal segment of the sciatic nerve, 24 h after crush injury. This result confirms our previous study, in which we proved that the increase in LRP1 mRNA was due to regulation of SC LRP1 gene expression (Campana et al., 2006) . Sciatic nerve crush injury also increased expression of NMDA-R subunits in distal segments, including NR1 (p<0.05, Fig. 8B ) and NR2b (p<0.05, Fig. 8D ). Although a trend towards increased NR2a mRNA expression was observed, the trend was not statistically significant ( Fig. 8C ).
MK801 blocks SC LRP1 signaling in vivo
Direct injection of the hemopexin domain of MMP-9 (MMP9-PEX) into crush-injured sciatic nerves activates ERK1/2 in SCs in a response that is LRP1-dependent, as determined by co-injection of RAP (Mantuano et al., 2008) . ERK1/2 activation is not observed when MMP9-PEX is injected into uninjured nerves, probably because the level of SC LRP1 is extremely low in the uninjured PNS. In this study, for the first time, we injected EI-tPA into sciatic nerves, immediately distal to the injury site, 24 h after crush injury. We also injected MMP9-PEX, to collect results with a second LRP1 ligand. Fig.   8E shows that in control, uninjured nerves, phospho-ERK1/2 was minimally activated, as anticipated (Mantuano et al., 2008) . When rats were treated systemically with MK801 for 45 min prior to harvesting uninjured nerves, little or no effect on ERK1/2 activation was observed.
Phospho-ERK1/2 remained only modestly activated in crush-injured sciatic nerves when the nerves were injected with vehicle, and once again, systemic preJournal of Cell Science Accepted manuscript treatment with MK801 failed to significantly affect this result. By contrast, as shown in Fig. 8E , direct injection of EI-tPA into crush-injured sciatic nerves robustly activated ERK1/2. Systemic treatment of the rats with MK801 (IP injection), for 30 min prior to injecting EI-tPA, blocked the response to EI-tPA. MMP9-PEX also activated ERK1/2 in crush-injured sciatic nerves, as anticipated (Mantuano et al., 2008) , and the response to MMP9-PEX was blocked by systemic administration of MK801. Overall, MK801
inhibited cell-signaling in vivo in response to one ligand (MMP9-PEX), which is known to bind only to LRP1, and to a second ligand (EI-tPA), which may bind to LRP1 and/or the NMDA-R. These results suggest that the NMDA-R is essential for LRP1 signaling in SCs in vivo in the injured PNS.
To confirm that ERK1/2 activation occurred in SCs when EI-tPA was injected into crush-injured sciatic nerves, we harvested tissue distal to the crush injury site and performed IF microscopy to detect phospho-ERK1/2, as previously described (Mantuano et al., 2008) . Fig. 8F shows that phospho-ERK1/2 IF was clearly present in nucleated, crescent-shaped SCs following EI-tPA injection. In animals that were pre-treated with MK801 systemically, SC-associated phospho-ERK1/2 IF appeared decreased. Although IF microscopy is not an appropriate technique to measure antigen levels quantitatively, the studies shown in Fig. 8F confirm that ERK1/2 is activated in SCs in vivo when EI-tPA is injected into injured sciatic nerves and the NMDA-R is un-inhibited.
Discussion
In this study, for the first time, we demonstrated that rat SCs express NMDA-R. We also elucidated an essential role for SC NMDA-R as a signaling receptor in response to proteins known to be present in the injured PNS. Our results support a model in which the NMDA-R may be an important regulator of SC physiology. SCs are known to release glutamate that interacts with neuronal NMDA-R (Wu et al., 2005) ; however, only a few previous reports have shown that NMDA-Rs are expressed by glia and may have significant functions in these cells. Satellite glial cells in DRGs apparently express the NMDA-R, which may contribute to interactions with neurons (Castillo et al., 2013) .
NMDA-R activation in satellite cells has been linked to sensitization of nociceptors and peripheral hyperalgesia (Ferrari et al., 2014) . The NMDA-R also has also been identified in oligodendrocyte precursor cells, where it may function in differentiation and myelination (Li et al., 2013) .
In astrocytes, the NMDA-R regulates production of the In conclusion, we have shown that SCs express the NMDA-R and that this receptor is a potentially important regulator of SC physiology in PNS injury. SC NMDA-R functions as a co-receptor for diverse LRP1 ligands and as an independent receptor for tPA, activating cell-signaling and promoting SC migration. The NMDA-R also promotes SC survival under challenging conditions.
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Materials and Methods
Proteins and reagents
α2M was purified from human plasma by the method of Imber and Pizzo (1981) and activated for binding to LRP1 by dialysis against 200 mM methylamine HCl (α2M*), as previously described (Gonias et al., 1982) . Modification of α2M by methylamine was confirmed by demonstrating the characteristic increase in α2M electrophoretic mobility by non-denaturing PAGE (Barrett et al., 1979) . EI-tPA and EA-tPA were purchased from 
IF microscopy analysis of crush-injured sciatic nerve
Distal sciatic nerve (0.3 cm) was recovered. The resected tissue was immersed in fixative for 2 h at 4°C and then transferred to 20% sucrose in PBS overnight. Serial 10 µm sections were prepared using a cryostat and mounted on Superfrost Plus Micro Slides (VWR, West Chester, PA). Polyclonal primary antibody, specific for phosphorylated ERK1/2 (1:500), was applied overnight at 4° C. After washing with Trisbuffered saline/Tween three times, the sections were incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG (5 µg/ml) for 1 h. In control studies, the primary antibody was omitted; no specific immunoreactivity was observed. Nuclei were stained with mounting medium containing DAPI (Invitrogen, Carlsbad, CA). All slides were coverslipped and visualized using a Leica DMIRE2 fluorescence microscope. Images were obtained using a 63x oil-immersion objective and a Hamamatsu digital camera with
SimplePCI software.
Statistical analysis
For all of the presented studies, replicates refer to separate experiments, typically performed with internal duplicates or triplicates. Results of cell migration, cell death, and in vivo cell-signaling experiments were subjected to analysis of variance (ANOVA). A Tukey's post hoc analysis was performed to assess differences between treatment groups. Rats were subjected to sciatic nerve crush injury (injured) or sham operation (uninjured).
24 h later, the rats were treated systemically with 0.1 mg/kg MK801 (+) or with vehicle (-). 30 min later, EI-tPA, MMP9-PEX (2 μL of 5 µM stock), or vehicle was injected directly into crush-injured nerves. Uninjured nerves were not injected. Nerve tissue distal to the injury site was harvested 15 min later. Immunoblot analysis was performed to detect phosphorylated ERK1/2 (p-ERK) and total ERK1/2 (T-ERK). The figure shows results
